Clinical significance of clonality assessment in JAK2V617F-negative essential thrombocythemia

Luz Martínez-Avilés, Alberto Álvarez-Larrán, Carles Besses, Gemma Navarro, Erica Torres, Raquel Longarón, Anna Angona, Carme Pedro, Lourdes Florensa, Sergi Serrano, Beatriz Bellosillo

Research output: Contribution to journalArticleResearchpeer-review

7 Citations (Scopus)


JAK2V617F-negative essential thrombocythemia (ET) is a heterogeneous disease including clonal cases and others without evidence of clonality. However, it is unknown if the detection of myeloid clonality in JAK2V617F-negative ET patients confers a different clinical outcome than those in whom clonal hematopoiesis cannot be demonstrated. The objective of the present study was to evaluate the clinical significance of clonality assessment in patients with JAK2V617F-negative ET. Clonality investigation including mutational status of MPL, TET2, and ASXL1 genes and human androgen receptor (HUMARA) assay was performed in 73 JAK2V617F-negative cases out of 186 subjects consecutively diagnosed with ET in a single institution, at diagnosis or during follow-up. Mutations in MPL, TET2, and ASXL1 were observed in 7, 4, and 2 cases, respectively, whereas clonality by HUMARA assay was demonstrated in 21 out of 46 (46 %) female patients. With a median follow-up of 8 years, death, thrombosis, bleeding, and disease transformation were registered in 7, 10, 8, and 6 patients, respectively. No differences in thrombosis, bleeding or survival were observed according to clonality assessment. The probability of disease transformation at 10 years was higher in patients showing clonal hematopoiesis by presenting mutations in either MPL, TET2, or ASXL1 (64 versus 2 % in patients without mutations, p<0.001) and in those with HUMARA clonality (35 versus 0 % in patients with polyclonal hematopoiesis, p<0.004). In conclusion, disease transformation is associated with evidence of clonality in JAK2V617F-negative ET. © Springer-Verlag 2012.
Original languageEnglish
Pages (from-to)1555-1562
JournalAnnals of Hematology
Issue number10
Publication statusPublished - 1 Oct 2012


  • Clonality
  • Disease transformation
  • Essential thrombocythemia

Fingerprint Dive into the research topics of 'Clinical significance of clonality assessment in JAK2V617F-negative essential thrombocythemia'. Together they form a unique fingerprint.

Cite this